WHO ICTRP trial
Study of pharmacodynamics, pharmacokinetics, safety and tolerability of VAY736…
EUCTR2017-002667-17-IE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2017-002667-17-IE |
|---|---|
| Public title | Study of pharmacodynamics, pharmacokinetics, safety and tolerability of VAY736 in patients with idiopathic pulmonary fibrosis |
| Scientific title | A subject-, investigator-, and sponsor-blinded, randomized, placebo-controlled, multicenter study to investigate efficacy, safety, and tolerability of VAY736 in patients with idiopathic pulmonary fibrosis |
| Primary sponsor | Novartis Pharma AG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;France;Canada;Ireland;Germany;United Kingdom;Italy |
| Conditions | Idiopathic pulmonary fibrosis MedDRA version: 21.1 Level: PT Classification code 10021240 Term: Idiopathic pulmonary fibrosis System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders ;Therapeutic area: Diseases [C]… |
| Interventions | Product Code: VAY736 Pharmaceutical Form: Powder for solution for injection/infusion INN or Proposed INN: not established Other descriptive name: VAY736 Concentration unit: mg milligram(s) Concentration type: equal Concentration number… |
| Registration date | Aug 11, 2017 |
| Target size | 58 |
| Secondary IDs | CVAY736X2207;NCT03287414;2017-002667-17-GB |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: